ANDREW S BOYER
CIK 1239546 · Executive Vice President · last filed 2026-03-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.21M
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$4.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMRX | Executive Vice President | 445,208 | $16.20 | $7.21M | -$4.27M | 33 | 2026-03-05 |
| Actavis, Inc. (WPI) Delisted | SVP,Sales&Mktg,US Generics | 38,913 | — | — | $0 | 9 | 2010-03-16 |
Recent Filings · Page 3 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-11 | AMRX | Mixed | +8,302 | -$43.4K | EDGAR |
| 2021-03-03 | AMRX | Grant (A) | — | $0 | EDGAR |
| 2021-03-02 | AMRX | Mixed | +21,515 | -$119.9K | EDGAR |
| 2020-08-04 | AMRX | Grant (A) | — | $0 | EDGAR |
| 2020-05-08 | AMRX | Mixed | +8,303 | -$29.7K | EDGAR |
| 2020-03-03 | AMRX | Mixed | +5,662 | -$25.7K | EDGAR |
| 2020-03-02 | AMRX | Grant (A) | — | $0 | EDGAR |
| 2019-11-14 | AMRX | Mixed | — | $0 | EDGAR |
| 2019-08-07 | AMRX | Buy (P) | +66,666 | $192.7K | EDGAR |
| 2019-05-13 | AMRX | Buy (P) | +19,000 | $179.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.